November 1, 2022
This is a major milestone in our US conquest and starting our in-house applications and materials development. Wake Forest’s WFIRM supports its partnering companies with a wide network of biotech professionals, scientists, FDA specialists, laboratories and in-house clinical testing facilities. Being accepted as a partner is not a small achievement as WFIRM only accepts companies that have a capability in developing FDA compliant applications through different in-vitro and in-vivo phases and receiving medical device status.
SO, WHAT ARE THE NEXT STEPS? First step is to get our new lead scientists to start in North Carolina, where we already have a designated office and laboratory space. Starting March 1, 2023, we will start our first applications, such as Cartilaginous Bio-Implants, Tunable Organ Tissue Equivalents, On-Demand Drug Formulations, and Wound Healing Bio-Bandages. At Wake Forest we also want our Brinter to help dozens of clinical applications they already have in progress. We believe that our in-house applications will be a huge step not only for Brinter, but will also change the Health Care forever!
-Tom Alapaattikoski, CEO, Brinter Inc
BRINTER – Where No Science Has Gone Before!
